A comprehensive view of Coalition for Epidemic Preparedness Innovations (CEPI). This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.
Moderna partners with CEPI to accelerate vaccine development for global viral outbreaks to 100 days through AI-generated antigen designs using Moderna’s mRNA platform, ensuring equitable access in low- and middle-income countries
Published:
October 30, 2023
by EquityBites
|
BioNTech and the Coalition for Epidemic Preparedness Innovations launch Phase 1/2 clinical trial for mRNA-based mpox vaccine program, BNT166, with US$90.0M CEPI funding; partnership aims to fast-track development of pandemic vaccines
Published:
September 18, 2023
by BioNTech SE
|
Ask us about our Health Care Sector market view